![Shachar Shlosberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 108 $ in data 30/06/2026
Shachar Shlosberger is currently the Chief Financial Officer at Enlivex Therapeutics Ltd. She previously worked as the Finance Director at Prolor Biotech Ltd. Shlosberger holds a Master's in Business Administration from The College of Management Academic Studies.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 9.288 ( 0% ) | 5 108 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENLIVEX | Direttore Finanziario/CFO | 01/01/2016 |
| Società | Posizione | Fine |
|---|---|---|
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 3 |
|---|---|
The College of Management Academic Studies
 The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
